[Clinical features and treatment of Hodgkin's disease].
Hodgkin's disease is characterized by its peculiar histopathology and by the early and consistent existence of impaired cell-mediated immunity, although its oncogenetic mechanisms still remains unsolved. Recent progress in multidisciplinary treatment including mainly radiotherapy and chemotherapy has a possible the cure of advanced Hodgkin's disease. In this article the main aspects of clinical behavior and therapy in Hodgkin's disease were reviewed briefly in the light of some considerations of our experiences.
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D005260:Female; D006689:Hodgkin Disease / Q000188:drug therapy / Q000276:immunology / Q000473:pathology*; D006801:Humans; D007111:Immunity, Cellular; D008297:Male; D008466:Mechlorethamine / Q000008:administration & dosage; D009367:Neoplasm Staging; D011241:Prednisone / Q000008:administration & dosage; D011344:Procarbazine / Q000008:administration & dosage; D011379:Prognosis; D014750:Vincristine / Q000008:administration & dosage
D011344:Procarbazine; D008466:Mechlorethamine; D014750:Vincristine; D011241:Prednisone